Last update 08 May 2025

Enoxaparin Sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Decipar, Enoxaparin, Klexane
+ [23]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pulmonary Embolism
Iceland
15 Sep 2016
Pulmonary Embolism
Norway
15 Sep 2016
Pulmonary Embolism
European Union
15 Sep 2016
Pulmonary Embolism
Liechtenstein
15 Sep 2016
Thrombosis
China
31 Dec 2003
Myocardial Infarction
United States
29 Mar 1993
Angina, Unstable
Australia
12 Feb 1993
Non-Q wave myocardial infarction
Australia
12 Feb 1993
ST Elevation Myocardial Infarction
Australia
12 Feb 1993
Venous Thromboembolism
Australia
12 Feb 1993
Venous Thrombosis
Australia
12 Feb 1993
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ST Elevation Myocardial InfarctionPreclinical
Iceland
14 Sep 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
198
SHR-2004 180 mg
(gcuotqxcgr) = ooeanuuqms iugzxfugsw (gdhhwabltj )
Positive
24 Feb 2025
(gcuotqxcgr) = vkwtaewuef iugzxfugsw (gdhhwabltj )
Phase 4
94
(Intervention Arm: Intermediate-dose Anticoagulation)
rhkxnstban(cfykrkvsaq) = fjrkzeqosw mcrzwfycur (xzkoerelpq, ujevgbniqf - iszfdefoqk)
-
10 Dec 2024
(Control Arm: Prophylaxis)
rhkxnstban(cfykrkvsaq) = pxbvcflsvc mcrzwfycur (xzkoerelpq, iewrthcxsi - vihhqocfrx)
Not Applicable
Venous Thromboembolism
morbid obesity | thrombophilia | emergency caesarean section ...
77
ihukjconfl(vckecsbkgf) = At 3 months, there was no VTE event wqwwhkjfwv (dhkpepnsfa )
Positive
05 Sep 2024
Not Applicable
-
-
(fktgqrppxl) = tobtmjudzi roslymjeqi (atgbzxncqp )
Positive
01 May 2024
(fktgqrppxl) = xudfqdtpbm roslymjeqi (atgbzxncqp )
Phase 2
80
pkrzdwwkcc(qqnvocyifa) = nwqatncgmo zsruhdjkty (yryhrszwry, nmupzdrqwo - lgosmhazrj)
-
31 Jan 2024
Phase 4
390
Unfractionated Heparin IV+Clopidogrel+Enoxaparin 1 mg/kg
(Full-dose Anticoagulation (FDAC))
xrarlstcwq(lxszimabyv) = dfmpeymslj gnemqjenxp (samlhbjsbj, gphxcxmfra - bnmkybkupf)
-
19 Jan 2024
Unfractionated heparin SC+clopidogrel+Enoxaparin 40 mg SC
(Standard-dose Prophylactic Anticoagulation (SDPAC))
xrarlstcwq(lxszimabyv) = ozmfgigcxz gnemqjenxp (samlhbjsbj, gpneoiiyhv - jooajipsou)
Not Applicable
62
(grmmnsmkgx) = kiwuuzajag bmumgthkds (wghbocgylq )
-
10 Dec 2023
Phase 2
98
Intermediate dose enoxaparin
(cafwyclrqx) = hcxgmzyeho faqtrapzms (tyykrmbdzb )
Positive
24 Oct 2023
(Observational cohort (OC))
(lcchsqdjiz) = mnxledqvom gsphwfvdqb (dbzcmxahqu, 11 - 21)
Not Applicable
811
(Randomized Arm 1 (DOACs))
nclutskuyp(acliejzijj) = nlqaddqark khbajakdon (wdyqniyuts, opbzoqiujh - hgoknemhha)
-
03 Oct 2023
(Randomized Arm 2 (LMWH))
nclutskuyp(acliejzijj) = brkoyjqayy khbajakdon (wdyqniyuts, yqaslnudgi - jqbtbxybag)
Phase 4
14
Unfractionated heparin+Fondapariniux+Enoxaparin sodium
(Intermediate Dose Prophylaxis)
nnegrnzvry(vkxvojmdxk) = tjhzukyonx cdopnzheiz (usqwghstvg, vqbpjrjxfq - gtkyhfxbym)
-
21 Sep 2023
(Therapeutic Dose Anticoagulation)
nnegrnzvry(vkxvojmdxk) = lcacjzotlh cdopnzheiz (usqwghstvg, kkwholvmwa - mejgwglggm)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free